Goitein M - Search Results

1

Trials and tribulations in charged particle radiotherapy.

Goitein M. Goitein M. Radiother Oncol. 2010 Apr;95(1):23-31. doi: 10.1016/j.radonc.2009.06.012. Epub 2009 Jul 4. Radiother Oncol. 2010. PMID: 19581014 Review.

2

Should randomized clinical trials be required for proton radiotherapy?

Goitein M, Cox JD. Goitein M, et al. J Clin Oncol. 2008 Jan 10;26(2):175-6. doi: 10.1200/JCO.2007.14.4329. J Clin Oncol. 2008. PMID: 18182658 No abstract available.

3

Technology evolution: is it survival of the fittest?

Zietman A, Goitein M, Tepper JE. Zietman A, et al. Among authors: goitein m. J Clin Oncol. 2010 Sep 20;28(27):4275-9. doi: 10.1200/JCO.2010.29.4645. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697074

4

Considerations in fractionated proton radiation therapy: clinical potential and results.

Austin-Seymour M, Urie M, Munzenrider J, Willett C, Goitein M, Verhey L, Gentry R, McNulty P, Koehler A, Suit H. Austin-Seymour M, et al. Among authors: goitein m. Radiother Oncol. 1990 Jan;17(1):29-35. doi: 10.1016/0167-8140(90)90046-y. Radiother Oncol. 1990. PMID: 2157240 Clinical Trial.

5

Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy.

Paganetti H, Goitein M, Parodi K. Paganetti H, et al. Among authors: goitein m. Radiother Oncol. 2010 Apr;95(1):79-86. doi: 10.1016/j.radonc.2009.03.020. Epub 2009 Apr 23. Radiother Oncol. 2010. PMID: 19394098

6

3D treatment planning for heavy charged particles.

Goitein M. Goitein M. Radiat Environ Biophys. 1992;31(3):241-5. doi: 10.1007/BF01214831. Radiat Environ Biophys. 1992. PMID: 1502332 Review.

7

Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

Niemierko A, Goitein M. Niemierko A, et al. Among authors: goitein m. Radiother Oncol. 1993 Nov;29(2):140-7. doi: 10.1016/0167-8140(93)90239-5. Radiother Oncol. 1993. PMID: 8310139

8

Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture.

Niemierko A, Goitein M. Niemierko A, et al. Among authors: goitein m. Radiother Oncol. 1991 Mar;20(3):166-76. doi: 10.1016/0167-8140(91)90093-v. Radiother Oncol. 1991. PMID: 1852908

9

Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.

MacKay RI, Niemierko A, Goitein M, Hendry JH. MacKay RI, et al. Among authors: goitein m. Radiother Oncol. 1998 Feb;46(2):215-6. doi: 10.1016/s0167-8140(97)00179-5. Radiother Oncol. 1998. PMID: 9510050 No abstract available.

10

Biophysical modelling of proton radiation effects based on amorphous track models.

Paganetti H, Goitein M. Paganetti H, et al. Among authors: goitein m. Int J Radiat Biol. 2001 Sep;77(9):911-28. doi: 10.1080/09553000110066059. Int J Radiat Biol. 2001. PMID: 11576451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters